节点文献

异机融合99Tcm-MIBI SPECT/CT对肺癌诊断的临床价值

Clinical evaluation of different-time 99Tcm-MIBI SPECT/CT fusion imaging in diagnosis of patients with lung cancer

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 吴波殷凯生陆国础卞涛叶万忠

【Author】 WU Bo,YIN Kai-sheng,LU Guo-chu1,BIAN Tao1,YE Wan-zhong2(Department of Respiratory Medicine,the First Affiliated Hospital of NJMU,Nanjing 210029;1Department of Respiratory Medicine,the People’s Hospital of Wuxi,Wuxi 214073;2Jiangsu Institute of Nuclear Medicine,Wuxi 214063,China)

【机构】 南京医科大学第一附属医院呼吸科无锡市人民医院呼吸科江苏省原子医学研究所

【摘要】 目的:探讨99Tcm-MIBIS PECT/CT异机融合断层显像对肺癌的临床诊断价值。方法:选择65例肺部占位性病变患者行99Tcm-MIBI SPECT/CT异机融合断层显像,分析显像结果,计算SPECT/CT断层融合显像的摄取比值(UR);依据病理诊断将患者分成肺癌组和良性病变组,以良性病变组UR的x+1s为诊断阈值,评价其对肺癌的诊断效能。结果:45例肺癌患者SPECT断层融合显像的UR为2.56±0.53;20例肺部良性病灶患者UR为1.47±0.42,差异有统计学意义(P<0.05);99Tcm-MIBI SPECT/CT异机融合断层显像对肺癌诊断的灵敏度、特异度和准确度分别为86.67%、85.00%、86.15%;假阳性率和假阴性率分别为15.00%和13.33%;阳性预测值和阴性预测值分别为92.86%和73.91%。结论:99Tcm-MIBI SPECT/CT异机融合断层显像对肺癌诊断有较高的临床价值,为制定治疗方案提供重要依据。

【Abstract】 Objective:To explore the clinical Value of different-time 99Tcm-MIBI SPECT/CT fusion imaging for the diagnosis of the lung cancer.Methods:Sixty five patients with pulmonary abnormal lesions were chosen for performing different-time 99Tcm-MIBI SPECT/CT fusion imaging.They were divided into lung cancer and benign groups according to the pathologic results.Then the results were analyzed.The uptake ratio(UR) was calculated.Finally the diagnostic efficacy of different-time 99Tcm-MIBI SPECT/CT fusion imaging for the lung cancer was evaluated by the threshold of x+1s of the lung benign group.Results:The UR value of 45 cases in lung cancer group was 2.56 ± 0.53 at the time of 60 min SPECT/CT fusion imaging,while 20 cases of benign group was 1.47 ± 0.42.There was a significant UR difference in two groups(P < 0.05).Using the x + 1s of benign group UR value as a threshold,the diagnostic sensitivity,specificity and accuracy of different-time 99Tcm-MIBI SPECT/CT fusion imaging for the lung cancer was 86.67%,85.00% and 86.15% respectively.The false positive and false negative rate were 15.00% and 13.33%.The positive and negative predictive value were 92.86% and 73.91%.Conclusion:Different-time 99Tcm-MIBI SPECT/CT fusion imaging may be used in the diagnosis of lung cancer with great value and it could provide the important clinical information for clinical treatment planning.

【关键词】 肺癌甲氧基异丁基异腈图像融合
【Key words】 lung cancerMIBIimage fusion
  • 【文献出处】 南京医科大学学报(自然科学版) ,Acta Universitatis Medicinalis Nanjing(Natural Science) , 编辑部邮箱 ,2008年09期
  • 【分类号】R734.2
  • 【被引频次】19
  • 【下载频次】117
节点文献中: 

本文链接的文献网络图示:

本文的引文网络